Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
News
135 news
-
Gustave Roussy Meets His Audience
Campaigns & Community OutreachAs part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur...
-
Mens November: Take care of your jewelry its precious!
Campaigns & Community OutreachNovember is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public...
-
Nuclear medicine: DART, a pioneering platform for the development of alpha therapy
Clinical & Scientific AdvancesDeveloped through a partnership between Gustave Roussy and the Paris-Saclay Cancer Cluster, the DART project aims to provide industry partners with a centre of excellence spanning...
-
Gustave Roussy at the ESMO 2026 Congress
Congresses, Conferences & EventsThe European Society for Medical Oncology (ESMO) is holding its annual congress from 23 to 27 October in Madrid, Spain. This major international event provides oncologists and...
-
5 questions with Dr François-Xavier Danlos about therapeutic cancer vaccines
InterpretationTherapeutic cancer vaccines are making significant progress in clinical development. The ESMO Congress, which begins on 23 October, will provide an opportunity to learn about new data on...
-
ADCs: Two Landmark Publications in Cancer Cell and Nature Medicine Showcase Gustave Roussy's Expertise
Clinical & Scientific AdvancesIn less than two months, researchers and clinicians from Gustave Roussy have contributed to two major publications on Antibody-Drug Conjugates (ADCs) in Cancer Cell and Nature Medicine...
-
Drug shortages: Gustave Roussy becomes the only Cancer Centre in France authorised to produce Special Hospital Preparations
InstitutionalThe Clinical Pharmacy Department at Gustave Roussy has been authorised by the French Ministry of Health to manufacture Special Hospital Preparations (SHPs). Granted for a period of seven...
-
Personalising Breast Cancer Treatments: 5 Questions with Dr Barbara Pistilli
Clinical & Scientific AdvancesAdvances in treatment and patient care mean that five-year net survival for breast cancer now reaches 88%1 in France. However, with around 60,000 new cases diagnosed each year in France...
8 results per page